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Abstract
Deciphering the potential of noncoding loci to influence gene regulation has been the
subject of intense research, with important implications in understanding genetic
underpinnings of human diseases. Massively parallel reporter assays (MPRAs) can
measure regulatory activity of thousands of DNA sequences and their variants in a
single experiment. With increasing number of publically available MPRA data sets,
one can now develop data‐driven models which, given a DNA sequence, predict its
regulatory activity. Here, we performed a comprehensive meta‐analysis of several
MPRA data sets in a variety of cellular contexts. We first applied an ensemble of
methods to predict MPRA output in each context and observed that the most
predictive features are consistent across data sets. We then demonstrate that
predictive models trained in one cellular context can be used to predict MPRA output
in another, with loss of accuracy attributed to cell‐type‐specific features. Finally, we
show that our approach achieves top performance in the Fifth Critical Assessment of
Genome Interpretation “Regulation Saturation” Challenge for predicting effects of
single‐nucleotide variants. Overall, our analysis provides insights into how MPRA
data can be leveraged to highlight functional regulatory regions throughout the
genome and can guide effective design of future experiments by better prioritizing
regions of interest.
K E YWORD S
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1 | INTRODUCTION
Massively parallel reporter assays (MPRA; Weingarten‐Gabbay &
Segal, 2014) provide cost‐effective, high‐throughput activity
screening of thousands of sequences and their variants for regulatory
activity (Kheradpour et al., 2013; Melnikov et al., 2012; Mogno,
Kwasnieski, & Cohen, 2013; Patwardhan et al., 2012; Sharon et al.,
2012; Smith et al., 2013). In these assays, a library of putative
regulatory elements is cloned and then transfected or infected into
cells of interest. Each element is either associated with a unique
barcode or can serve as a unique barcode itself (Arnold et al., 2013).
The activity associated with each given regulatory element (i.e.,
MPRA output) is assessed by sequencing the transcribed barcodes
and estimating the ratio between the transcribed RNA and the
construct’s DNA. As MPRA is still a nascent technology, the
development of computational tools that take advantage of existing
MPRA data sets could help improve future MPRA candidate
sequence selection, enhance our ability to predict functional
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regulatory sequences, and increase our understanding of the
regulatory code and how its alteration can lead to phenotypic
consequences.
Previous work have used single MPRA data sets to better identify
functional DNA sequences and then study the features that make a
sequence regulatory active (Grossman et al., 2017; Lee et al., 2015;
Sharon et al., 2012). For example, in the expression quantitative trait
loci (eQTL) causal SNP challenge of the Fourth Critical Assessment of
Genome Interpretation (CAGI4) community experiment, participants
developed methods for predicting regulatory activity of candidate
genomic regions and the effect of minor variants on their regulatory
potential in MPRA (Beer, 2017; Kreimer et al., 2017; Zeng, Edwards,
Guo, & Gifford, 2017). The main lessons learned from this community
effort highlighted the effectiveness of ensembles of nonlinear
methods, especially when used on features related to transcription
factor (TF) binding and chromatin accessibility. Interestingly, epige-
netic properties predicted from DNA sequence (Alipanahi, Delong,
Weirauch, & Frey, 2015; Zeng, Hashimoto, Kang, & Gifford, 2016; J.
Zhou & Troyanskaya, 2015) were shown to be more predictive
features than experimentally measured epigenetic properties.
Although these efforts provided an important first step, each of
them focused on a single MPRA data set in a specific cellular context.
Critical questions, therefore, remain as to how generalizable the
insights from MPRA experiments are to other data sets or other
cellular contexts. Here, we present a first comprehensive analysis of
several MPRA data sets collected by different labs and in various
cellular systems; these data sets explore the effect of endogenous
loci in several different cell‐types. We derive a large set of properties
to characterize each putative regulatory region and compare the
performance of different methods and features for predicting MPRA
output. We show that MPRA activity is predictable and that
prediction methods tend to perform consistently well when tested
on different data sets, with better performance for nonlinear
methods and favorable results when using an ensemble approach.
Consistently, the predictive capacity of individual features is
comparable across data sets, with TF binding and epigenetic
properties being the top predictors.
We next turned to investigate the generalizability of our models
across data sets, which allowed us to distinguish between determi-
nants of MPRA activity that are dependent on the cellular context
(e.g., protein milieu in the cell) versus ones that are intrinsic to the
DNA sequence. Here, we demonstrate that predictive models trained
in one cellular context can be used to predict the MPRA output in
another with reduced prediction power and that, as expected,
regions whose activity is cell‐type specific are harder to predict in
this cross‐ data set setting. We also observe that gene expression of
TFs is overall consistent with the predictive ability of their binding
instances, with highly expressed TFs being generally more predictive
of MPRA activity. When comparing pairs of data sets for TFs that are
predictive of MPRA activity, we notice that in some cases, TFs with
cell‐type‐specific functionality are better predictors in that cell‐type.
In addition, we wanted to evaluate the applicability of our
predictive models in studying the function of naturally occurring
mutations. We, therefore, tested the ability of our framework to
detect the effects of small variants—single‐nucleotide variants (SNV)
or short insertions or deletions (indels)—on MPRA activity and
achieved similar accuracy to the state of the art methods (Zeng et al.,
2017). Finally, we applied our approach to the Regulation Saturation
challenge of the Fifth Critical Assessment of Genome Interpretation
(CAGI5), and demonstrate that it achieves top performance in
identifying functional effects of SNVs in supervised settings.
2 | METHODS
2.1 | MPRA data sets
We used five publicly available MPRA data sets and one unpublished
data set. (a) K562—putative regulatory regions (Kwasnieski et al., 2014)
selected from ENCODE‐based annotated regions in K562 cells (Encode‐
Project‐Consortium, 2012; Ernst & Kellis, 2010; Hoffman et al., 2013).
This set includes 600 regions annotated as enhancers, 600 as weak
enhancers, 300 as repressed in K562 cell line, 600 enhancer predictions
from the H1hESC cell line that are not annotated as weak enhancers or
enhancers in K562 cells, and 1,136 negative controls—random sequences
from each class above were chosen and scrambled while maintaining
dinucleotide content. The regions range from 121 to 130 base pairs and
were tested in episomal context in K562 cells. Data from all sequences
were used to fit MPRAnalyze, although only the 1,500 regions annotated
with the K562 cell line were used in the remaining analyses. (b) LCL‐eQTL
—78,738 regions (Tewhey et al., 2016) that contain an eQTL in LCLs, 150
base pairs, tested in episomal context in LCL. (c) HepG2‐eQTL—the same
set of elements (Tewhey et al., 2016) as above, tested in episomal context
in HepG2 cell line instead of LCL. For both data sets 2 and 3, all of the
78,738 regions were used to fit MPRAnalyze, whereas 3,044 regions
corresponding to the first test group in the CAGI4 challenge (Kreimer
et al., 2017) were used for the remaining analyses. (d) HepG2‐chr—2,236
candidate liver enhancers (Fumitaka Inoue et al., 2017) and 102 positive
and 102 negative control sequences. Each sequence is 171 base pairs and
tested in chromosomal context. (e) HepG2‐epi— the same set of elements
(Inoue et al., 2017) as above, tested in episomal context. For both data
sets 4 and 5, all regions were used to fit MPRAnalyze and the 2,236
candidate enhancer regions were used for the remaining analyses. (f)
hESC—2,464 putative enhancer regions (Inoue et al., 2018) and 200
negative controls. Each region is 171 base pairs and tested in
chromosomal context in hESC cell line. All regions were used to fit
MPRAnalyze, whereas only the 2,268 candidate enhancer regions were
used for the remaining analyses.
2.2 | Quantifying activity of regions using
MPRAnalyze
For each data set, we obtain the RNA and DNA raw counts for each
barcode. We obtain a quantitative measure of enhancer‐induced
transcription using MPRAnalyze (Ashuach et al., 2019). MPRAnalyze
assumes a linear relationship between the RNA and DNA counts,
with the scaling parameter, denoted ɑ, as the transcription rate. The
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method uses a parametric graphical model to incorporate external
covariates and dispersion estimates into quantifying ɑ.
The MPRAnalyze model assumes the DNA counts are
Gamma‐distributed and that given the latent plasmid count, the
RNA counts are Poisson‐distributed centered around the product of
the plasmid count and ɑ. This results in a closed‐form negative‐
binomial likelihood function for the RNA counts. External covariates
such as barcode effect, batch effects and conditions of interest are
then incorporated into the model by constructing a pair of nested
generalized linear models: One using the DNA counts to estimate the
latent plasmid counts, and the other using these latent plasmid
counts along with the RNA raw counts to estimate ɑ.
Classification of active/inactive enhancers is done by using the
fitted ɑ values. If a data set has control regions (K562 and hESC), we
first calculate a robust version of the standard score from the ɑ
values by subtracting the median over the control regions and
dividing by the median absolute deviation (MAD) of the control
regions. If no control region exists for the data set, we perform the
previous step with the median and MAD over all regions instead of
just the control regions. We then compute the survival function for
each standard score and apply the Benjamini–Hochberg (BH)
correction. The active regions are then defined as regions with a
false discovery rate (FDR) of less than 0.05.
2.3 | Features
We assessed the correlation of 56 single features (Table S1) with
MPRA activity.
(a) #GC; #polyA, #polyT—number of G/C in the sequence; length of
longest polyA/T subsequence. (b) #5‐mers—number of distinct 5‐mers in
the sequence. (c) MGW, Roll, ProT, HelT—DNA shape features (T. Zhou
et al., 2013) quantifying minor groove width, roll, propeller twist, and
helix twist. (d) Conservation—evolutionary conservation score of region as
predicted by phastCons (Siepel et al., 2005). (e) Closest Gene Expression—
expression (TPM) of the closest gene from RNA‐seq data in the
corresponding cell‐type. (f) Promoter, Exon, Intron, Distal —binary features
indicating whether the element intersects a promoter, exon, and intron.
Distal is defined to be 1 if the element does not intersect with either
promoter, exon, or intron annotations. (g) #motifs, Motif Density—number
of significant DNA‐binding ENCODE motifs (Encode‐Project‐Consortium,
2012) from simple DNA‐binding motif scoring (Grant et al., 2011),
maximum number of motifs within a 20bp window in the sequence. (h)
#deepsea‐top, #deepbind‐top—number of TFs quantifications above 90th
percentile across all the regions predicted by DeepSEA / DeepBind. (a)
#tf‐high, #tf‐med, #tf‐low—number of TFs that are bound above 90th
percentile by DeepBind and rank in the top, middle, or bottom 100 (out of
515) for RNA‐seq TPM in the relevant cell‐type. Note that for both (h)
and (i), we do not retrain the DeepSEA and DeepBind models with
additional data, but instead use the pre‐trained models to score each
MPRA sequence. (j) <factor>[Cell] Mean, TFBS Shuffled Mean—mean across
subsets of Experimental features. <factor> can be TFBS, DNase, CTCF, Ezh2,
H2az, H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me1, H3K9me3,
H3K27ac3, H3K27me3, H3K36me3, H3K79me2, H4K20me1, P300. For
these factors we take the mean of the binary overlaps over all
corresponding [, cell‐type specific to the data set’s cell‐type,] Experimental
features. TFBS Shuffled Mean is the mean across n non cell‐type specific,
randomly chosen TFBS features, where n is the number of features in
TFBS Cell Mean.
2.4 | Statistical tests
We examine the predictivity of features and accuracy of prediction
models using several statistical tests. For regression task—for example,
predicting quantitative activity—we applied several correlation measures
(Pearson, Spearman, and Kendall) considering either the entire test data
or regions at the top 25% of quantitative activity; we also applied another
Spearman’s correlation test after first binning quantitative activity by
quintiles. We refer to these seven tests as the regression tests. For
classification task—for example, predicting active or not active—we
record the area under receiver operating characteristic curve (AUROC)
and area under precision‐recall curve (AUPRC); we refer to these two
tests as the classification tests. The significance of each regression task was
evaluated by the respective statistical test q‐values, which are obtained
from p‐values via the Benjamini–Hochberg correction. The significance of
classification was evaluated by the q‐values of the Kolmogorov–Smirnov
test on the predictions with positive ground truth labels.
2.5 | Training and testing
We deterministically divide each data set into 10 sections; data sets
with the same regions (LCL‐eQTL and HepG2‐eQTL, and HepG2‐chr
and HepG2‐epi) are divided consistently. For the supervised case, we
perform 10‐fold cross‐validation where each fold trains the model on
nine training sections then evaluating on the remaining section. For
the cross‐data set case, we perform 10‐fold cross‐validation where
each fold trains the model on nine sections from the training data set,
then evaluating on the corresponding remaining section in the last
data set. We use the statistics from each fold to calculate the overall
mean and standard deviation statistics.
When comparing cross‐data set learning performance between
training on chromosomal MPRA data (HepG2‐chr) versus training on
episomal MPRA data (HepG2‐epi), we observe that training on
HepG2‐chr showed better results than HepG2‐epi 37 out of 40 times
(comparing results across different statistical tests; Figure 3 and
Table S4). Same regions were used for training and testing was done
on the other four data sets.
2.6 | Prediction models
We predict the quantitative activity from element features with four
regression models and their ensemble. The four models are a linear
regressor with ElasticNet regularization (Zou & Hastie, 2005) with 0.5 as
the L1 and L2 regularization coefficients and a RandomForest regressor
(Breiman, 2001), an ExtraTrees regressor (Geurts et al., 2006), and a
GradientBoosting regressor (Zhu et al., 2009), each with 1,000
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estimators. The ensemble method is implemented by taking the average
prediction of all four regression models.
For the classification task, we use a RandomForest classifier
(Breiman, 2001) and an ExtraTrees classifier (Geurts et al., 2006),
each with 1,000 estimators, as well as their ensemble. The ensemble
method averages the predicted probability from each classifier.
For both regression and classification, we define a shuffle model
with the same composition as an ensemble model but shuffles the
labels of the training set before training. This allows us to quantify
the probability of producing our ensemble results by chance.
2.7 | CAGI5 data processing
We predicted the variant impacts (positive, zero, negative) of 13,186
SNVs from five enhancers and nine promoters after training on 4,650
different SNVs from the same enhancers and promoters. For each SNV,
we obtained the variant and wild‐type sequence, each of length 187–600,
then featurized both variant and wild‐type with the 4,535 features that
differ between variant and wild‐type: Predicted epigenetic properties, DNA
k‐mer frequencies, #GC, #polyA/T, DNA shape features, and conservation;
we collectively referred to these features as Sequence features.
For the discrete challenge, we concatenate the features from
variant and wild‐type into a feature vector of size 9,070. We trained
one multiclass classifier to predict the discrete impact for all
promoter variants at once, and another classifier for the enhancer
variants. For submitting to the continuous challenge, we used the same
feature processing steps as in the discrete challenge, but trained
regressors to predict the continuous impact.
We retrospectively discovered that concatenating wild‐type/variants
features performs identically to taking their difference; we also
retrospectively discovered that training a classifier for all promoters
(enhancers) together performs better in classification, whereas training a
separate regression per element performs better in regression. As such,
for all analyses of the continuous challenge besides the original submission,
F IGURE 1 Individual feature
correlation with massively parallel reporter
assay output. The within‐data set ranking
is calculated by first ranking each feature
by each test, then taking the median of the
regression and classification test rankings.
The comprehensive ranking is the median
across all the data set rankings. The
heatmaps are ordered according to the
comprehensive ranking and colored
according to (a) the within‐data set rank,
(b) the Spearman correlation coefficient for
regression task, and (c) the area under
receiver operating characteristic curve
value for classification task
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we subtracted the corresponding wild‐type features from each of the
4,535 variant features and used this difference in features to predict the
continuous impact via regression, separately for each element
(enhancer/promoter).
2.8 | CAGI5 models
Each multiclass classification model used in discrete challenge is an
ensemble of five RandomForest classifiers and five ExtraTrees
classifiers, trained to predict the discrete impact class (positive, zero,
negative).
Each regression model used in the continuous challenge for
predicting promoter variants (or predicting all promoter variants at
once) is an ensemble of one RandomForest regressor, one ExtraTrees
regressor, and one GradientBoosting regressor, whereas each
regression models used for predicting enhancer variants (or
predicting all enhancer variants at once) is an ensemble of five
RandomForest regressors and five ExtraTrees regressors.
Each classifier or regressor consists of 1,000 estimators, and each
estimator used in RandomForest or ExtreTrees models considers the
square root of the total number of features when looking for best
split.
3 | RESULTS
We used five publicly available MPRA data sets and one unpublished
data set collected at several labs using a range of experimental
methodologies and cell‐types (Section 2). In all cases, the MPRA
constructs were designed to test endogenous human DNA
sequences, and not in‐silico designed synthetic sequences (Smith
et al., 2013). Thus, each element tested in each data set is associated
with a source genomic region. Each data set consists of approxi-
mately 2,000 sequences with length that varies between 121 and
171 base pairs (Section 2). Unless otherwise noted, the MPRA
experiment was performed in an episomal context. The first data set
(Kwasnieski, Fiore, Chaudhari, & Cohen, 2014), which we refer to as
K562, consists of putative regulatory regions selected from
ENCODE‐based annotated regions in K562 cells (Encode‐Project‐
Consortium, 2012; Ernst & Kellis, 2010; Hoffman et al., 2013). The
second and third data sets, which we refer to as LCL‐eQTL and
HepG2‐eQTL (Tewhey et al., 2016), consist of sequences that contain
F IGURE 2 Performance of (a) regression models and (b) classification models with different feature combinations. The within‐data set
ranking is calculated for each cell by taking the median of the rankings for all the (a) regression or (b) classification tests within a data set. Each
heatmap is colored according to the within‐data set rankings. The statistics are mean ± standard deviation for (a) Spearman and Kendall tests or
(b) area under receiver operating characteristic curve and area under precision‐recall curve tests
F IGURE 3 Performance of cross‐data set learning for (a)
regression task and (b) classification task between cell‐types. All
cross‐ data set learning models are ensemble models with full
features. Each cell is colored according to the median over the ranks
of all (a) regression tests or (b) classification tests. The statistics are
mean ± standard deviation of (a) Spearman and Kendall tests or (b)
area under receiver operating characteristic curve and area under
precision‐recall curve tests
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an eQTL in lymphoblastoid cell lines (LCLs). The same sequences
were tested in LCL and HepG2 cells, thus forming the two data sets.
Notably, the LCL‐eQTL data set was used as the primary source for
the CAGI4 eQTL causal challenge (Kreimer et al., 2017). The fourth
and fifth data sets (Inoue et al., 2017) include candidate liver
enhancers, tested in either episomal or chromosomal context. We
refer to these data sets as HepG2‐epi (for MPRA plasmids) and
HepG2‐chr (for MPRA integrated in the genome). The sixth data set
includes putative enhancer regions (Inoue, Kreimer, Ashuach, Ahituv,
& Yosef, 2018) tested in chromosomal context in human embryonic
stem cells (hESC). We refer to this data set as hESC.
Separately, for each data set, we applied MPRAnalyze (Ashuach,
Fischer, Kreimer, Theis, & Yosef, 2019; Section 2; Figures S1–S3), a
new tool for statistical analysis of MPRA data developed in our
group, to obtain (a) MPRA output: A quantitative measure of
enhancer‐induced transcription, computed as the ratio between the
estimated abundances of transcribed RNA and the construct’s DNA.
These values are estimated by constructing a nested pair of
generalized linear models that extract the ratio RNA/DNA as a
measure of activity while controlling for various confounding factors,
and (b) a binary label that identifies active/inactive enhancers,
namely enhancers whose activity significantly deviates from that of
the negative controls (median‐based z‐score; FDR < 0.05).
The CAGI5 Regulation Saturation challenge, also titled “Predict-
ing individual non‐coding variant effects in disease associated
promoter and enhancer elements,” experimentally assessed the
effects of 17,500 SNVs in 14 regulatory elements that are associated
with human disease. Specifically, nine promoters (F9, GP1BB, HBB,
HBG, HNF4A, LDLR, MSMB, PKLR, and TERT) and five enhancers
(IRF4, IRF6, MYC, SORT1, and ZFAND3) of lengths 187–600 base
pairs (bps) were tested with saturation mutagenesis for MPRA
activity in a relevant cell‐type (HepG2, HEL 92.1.7, HEK293T, K562,
GBM, SK‐MEL‐28, HaCaT, and MIN6; Kircher et al., 2018).
3.1 | Predictive features for MPRA activity are
consistent across data sets
We first defined a set of features that characterize each MPRA
sequence and inspected each feature individually (Section 2; see
Table S1 for a complete description of all features). Overall, we
examined 56 features that can be divided into four categories
(similarly to Kreimer et al. (2017)). (a) Experimentally measured
epigenetic properties: To define these, we mapped each assayed
region to its corresponding position in the reference human genome,
and then queried this position against tracks of epigenetic properties
from ENCODE (Encode‐Project‐Consortium, 2012). These properties
were measured in multiple cell lines and include the overall number
of observed TF binding sites (TFBS), histone marks, binding by
chromatin structure‐associated proteins (e.g., P300), chromatin
accessibility (primarily by identifying DNase‐hypersensitivity sites;
henceforth abbreviated as DHS), and DNA‐ methylation. For all these
features we either aggregate over all available cell‐types, or restrict
the analysis to the same cell‐type in which the MPRA was conducted.
(b) Predicted epigenetic properties: This set of features covers similar
properties as the experimentally derived ones (e.g., TFBS or histone
marks). However, instead of being directly measured, the properties
are inferred based on the DNA sequence of the respective MPRA
construct, using models trained on experimental data (e.g.,
protein‐binding microarrays for TFBS [Newburger & Bulyk, 2009]
or ChIP‐seq for histone marks [Encode‐Project‐Consortium, 2012]).
We use three models for this purpose: scoring of protein‐DNA‐
binding motifs (Grant, Bailey, & Noble, 2011), the more recent
supervised methods DeepBind (Alipanahi et al., 2015), and DeepSEA
(J. Zhou & Troyanskaya, 2015). In all three cases (motif scoring,
DeepBind, and DeepSEA), we do not retrain the models with additional
data, but only use the pre‐trained models to score each MPRA
sequence. Another feature included here is Motif
Density—defined as the maximum number of protein‐DNA‐binding
motifs within a 20 bp window in the MPRA sequence. (c) DNA k‐mer
frequencies using k = 5. And (d) Additional locus specific features: Here
we used the number of G/C in the sequence (#GC) as well as the
length of longest polyA/T subsequence (#polyA/T). We also used DNA
shape features (T. Zhou et al., 2013) quantifying minor groove width,
roll, propeller twist, and helix twist (MGW, Roll, ProT, and HelT
respectively). Additional features in this category include: Conserva-
tion—evolutionary conservation score of region as predicted by
phastCons (Siepel et al., 2005). Closest Gene Expression—expression
(TPM) of the closest gene from RNA‐seq data in the corresponding
cell‐type. Promoter, Exon, Intron, Distal—binary features indicating the
respective location in the endogenous genome.
We use these 56 features (Section 2; Table S1) individually in two
ways: (a) we test how well each feature correlates with the
quantitative MPRA output of each data set using seven regression
tests (Section 2) and (b) we test how well each feature discriminates
between active and inactive regions using two classification tests
(Section 2). We rank each feature for each of the nine tests and then
take the median of these ranks to obtain a data set‐specific feature
ranking. We then take the median across all data set‐specific ranking
to obtain a global ranking of the features and sort them according to
their global rank (Figure 1). Notably, the different statistical tests are
largely consistent with the global rank (Figure 1 and Table S1),
supporting its robustness. This global rank highlights chromatin
accessibility (DNase Mean) and the number of TF binding sites (TFBS
Mean) as the most predictive features for MPRA activity across all
data sets. To gauge the robustness of our results, we repeated the
above feature correlation experiments 100 times, each time sampling
80% of the loci in the data, and report the mean and standard
deviation of the resulting accuracy (Table S1).
To further explore cell‐type specificity in the context of TF
binding, we stratified the TFs into three groups according to their
expression level in the cell‐type of interest (low/intermediate/high)
and sum over the number of binding sites in each group. Although
these three features #tf‐high, #tf‐med, #tf‐low had a strong
correlation (especially #tf‐high) with MPRA activity (Figure 1), they
are still less predictive than TFBS Mean (the simple mean across all
TFBS‐related features). Consistently, we found several cell‐type
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agnostic features such as GC content and #motifs that are predictive
of MPRA activity as well (Figures 1, S4, and S5).
Furthermore, we found that limiting the set of TFs in a manner
specific to the cell‐type under investigation (e.g., for the K562 data
set, TFBS Cell Mean only considers TF ChIP‐seq experiments
conducted in K562 cells) does not improve accuracy (Table S1),
compared with taking all available data regardless of cell‐type of
origin (TFBS Mean). This observation is consistent with previous work
on enhancer annotation, showing that integration of diverse data sets
from different cellular contexts improves developmental enhancer
prediction over approaches based on single context data (Erwin et al.,
2014). As additional control, we randomly subsampled N (the number
of TFs used to calculate TFBS Cell Mean) ChIP‐seq experiments that
were conducted in a cell‐type different from the one used for MPRA,
and computed the mean number of binding sites. Consistent with the
results above, we found that the predictive capacity of this random
set of TFs‐binding scores (considering 100 randomly selected sets for
each of our six data sets; denoted TFBS Shuffled Mean) is not lower
than that of ChIP‐seq experiments conducted in cell‐type in which
MPRA was conducted (empirical p > 0.25).
The CAGI5 saturation mutagenesis data set consists of a small
number of endogenous genomic regions, selected in large under the
assumption that they play important regulatory role in the respective
cellular context. Indeed, these regions show significant amount of
MPRA activity when tested in their corresponding cell‐types (Kircher
et al., 2018). As such, one would expect that these regions might
exhibit higher than usual values in the aforementioned set of
features. To test this, we featurized these 14 regions as above and
compared the signal of each feature to the distribution of the same
features across regions in LCL‐eQTL data set and reported the
percentile per feature (Figure S6). We chose LCL‐eQTL as the
background distribution since regions tested in this experiment were
selected based on harboring an eQTL variant, which provides a
potentially weaker indication for regulatory activity (Tewhey et al.,
2016; as opposed to experimental designs that selects for regions
that are enriched with regulatory element marks—e.g., H3K27ac
peaks). As CAGI5 regions have varying lengths, we focused our
analysis on 150 bp in the center of each region (corresponding to
sequence lengths of 150 bp in LCL‐eQTL). As expected, for the most
predictive features, we observe a higher than median signal in CAGI5
tested regions comparing with LCL‐eQTL regions (Figure S6).
3.2 | Predictive models of MPRA activity are
similar across data sets
Next, we turned to the construction of supervised models that are
trained to predict the MPRA output either as a quantitative measure
of enhancer activity (i.e., regression task) or as a binary label that
distinguishes between active and inactive enhancers (i.e.,
classification task). To this end, we considered a collection of
regression models (Elastic Net [Zou & Hastie, 2005], Random Forest
[Breiman, 2001], Extra Trees [Geurts, Damien, & Louis, 2006], Gradient
Boosting [Zhu, Zou, Rosset, & Hastie, 2009], and ensemble) and
classification models (Random Forest [Breiman, 2001], Extra Trees
[Geurts et al., 2006], ensemble), which we applied separately for each
data set. We trained these models using a set of features that
extends the one investigated in Figure 1, with the following
categories: (a) Experimentally measured epigenetic properties—1,095
binary features based on ENCODE data (Encode‐Project‐Consortium,
2012). These features indicate whether the genomic region overlaps
with experimentally measured tracks of: TFBS from ChIP‐seq
experiments, histone modifications, and DNase‐hypersensitivity sites
across different cell‐types (Table S1). (b) Predicted epigenetic
properties—This set consists of three sources: (a) DeepBind—515
features, each indicating a binding score of a certain TF, predicted by
a sequence‐based neural network model trained on protein‐binding
microarrays (Alipanahi et al., 2015). (b) DeepSEA—919 binary
features, indicating predictions of various events related to
chromatin structure, namely TF binding, DNA accessibility, and
histone modifications. These events were predicted by a
sequence‐based neural network model trained on ENCODE data (J.
Zhou & Troyanskaya, 2015). (c) Motifs—2,065 binary features
indicating motif hits (Encode‐Project‐Consortium, 2012; Grant
et al., 2011; Kheradpour & Kellis, 2014). (c) DNA k‐mer frequencies
—1,024 binary features, indicating the presence or absence of all
possible nucleotide 5‐mers. (d) Additional locus specific features as in
Figure 1 (Table S1).
We evaluate the accuracy of prediction in each combination of
data set × prediction method × feature category using 10‐fold cross‐
validation. We report the mean and standard deviation of the
resulting scores (Figure 2). Importantly, we do not use our evaluation
of individual features in Figure 1 during model training (e.g., for
feature selection), thus avoiding circularity.
Reassuringly, the accuracies of our top model for predicting
MPRA activity on the LCL‐eQTL data set (regression and
classification: 0.4 Spearman’s correlation and 0.79 AUROC,
respectively) matched that of the top ranking group in the CAGI4
challenge (0.34 Spearman’s correlation and 0.8 AUROC; Zeng et al.,
2017). Consistent with our results for single features, we observe an
overall agreement in our results across data sets, both in terms of the
relative performance of each algorithm, and in terms of the
importance of each feature category. Specifically, we observe that
nonlinear methods perform better (e.g., cf. elastic net to random
forest) and that an ensemble approach (aggregating over all
classifiers or regression methods) tends to have the highest
performance (Figure 2 and Table S2). Among the feature categories,
the predicted TF binding properties according to DeepBind are top
performers, and the union of all feature categories generally yields
the best performance, indicating that even with a large feature set
the various models still do not over‐fit. To further test this, we
trained our models on shuffled labels (Section 2), and observed that
the performance significantly decreases in all cases, including the
more complex ensemble model that uses the complete feature set.
Another result consistent with the ones observed with single
features regards the importance of cell‐type specificity, where we
again noticed that limiting the epigenetic features to be cell‐type
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specific does not increase accuracy (Figure S7 and Table S3). Finally,
it is interesting to note that the accuracy achieved with a
chromosomal MPRA library in HepG2 cells (HepG2‐chr) tends to be
slightly higher than the one obtained with an episomal library
(HepG2‐epi; regression: 0.59 vs. 0.45 Spearman correlation and 0.41
versus 0.31 Kendal correlation; Figure 2). These results are
consistent with a recent comparison between these two
experimental approaches (Inoue et al., 2017) that found chromoso-
mal MPRA to be more reproducible, have higher correlation with
epigenetic marks and work in variety of cell‐types that are harder to
transfect (e.g., hESCs); however, more data sets are required to
substantiate this finding.
3.3 | Transferring knowledge between cell‐types
Using existing MPRA data to build models that can be applied across
different cellular backgrounds and for genome‐wide predictions of
regulatory elements can be useful for prioritizing functional
regulatory regions, which can guide the design of new MPRA panels
and used for analysis purposes. To evaluate how well our models
generalize to a new cellular context where MPRA data is not
available, we tested the extent to which models trained in each data
set can be used to predict the outcome in the remaining data sets.
Based on the results in Figure 2, we take the Full set of features (i.e.,
all feature categories) and use the ensemble model for both the
regression and classification tasks. We avoid training on any genomic
region from one data set (e.g., LCL‐eQTL) that is already in the test set
from another data set (e.g., HepG2‐eQTL).
We observe that performance in the regression task is reduced in
this cross‐data set setting compared with the supervised setting. For
example, for the K562 regression task, the best model trained on
K562 data achieves a cross‐validation Spearman of 0.58 (Figure 2
and Table S2), whereas the best models trained on LCL‐eQTL, HepG2‐
eQTL, HepG2‐chr, HepG2‐epi, hESC data set only achieve Spearman’s
correlations of 0.23, 0.21, 0.44, 0.3, 0.33, respectively (Figure 3 and
Table S4). However, performance in the classification task is
generally robust. For example, for the K562 classification task, the
best model trained on K562 data achieves an AUROC of 0.85 (Figure
2), whereas the best models trained on LCL‐eQTL, HepG2‐eQTL,
HepG2‐chr, HepG2‐epi, hESC achieve AUROCs of 0.7, 0.67, 0.75, 0.74,
0.68, respectively (Figure 3 and Table S4). These results suggest that
MPRA data in one cellular context can be leveraged to distinguish
between regions of regulatory importance in another.
We hypothesized that genomic regions that are uniquely active in
a certain cell‐type would be harder to predict in a cross‐data set
setting. To explore this, we took advantage of the LCL‐eQTL and
HepG2‐eQTL data sets, which include the same set of genomic
regions. We first examined the distribution of three region categories
in these two data sets (Figure 4a): common regions (i.e., active
regions in both data sets), cell‐type‐specific regions (i.e. regions
active in one of the data sets), and inactive regions (i.e., regions not
active in both data sets). We then examined prediction performance
for each of the region categories (Figure 4b) in cross‐data set analysis
where we apply the classifier built on one data set to annotate
regions in the other data set as active or not. To assess this, we
defined the “hardness” of the region based on the difference between
the predicted score (in range [0, 1]) and the class label (1 for active
and 0 for not‐active region). Reassuringly, we observe that cell‐type‐
specific regions are harder to predict in cross‐data set learning
(Figure 4b). These results suggest that while the MPRA signal can be
predicted to some extent using cell‐type agnostic components, it also
depends on cell‐type‐specific ones. Interestingly, and consistent with
our cross‐validation (i.e., per‐ data set) analysis, we observe that the
cross‐data set accuracy achieved with models trained on chromoso-
mal MPRA library (HepG2‐chr) is higher (0.33, 0.28, 0.3, 0.31
Spearman’s correlation and 0.53, 0.6, 0.63, 0.63 AUC for K562,
LCL‐eQTL, HepG2‐eQTL, hESC respectively) than the one obtained
with an episomal library (HepG2‐epi; 0.4, 0.32, 0.35, 0.37 Spearman’s
correlation and 0.61, 0.66, 0.72, 0.7 AUC for K562, LCL‐eQTL, HepG2‐
eQTL, hESC, respectively; Section 2; Figure 3 and Table S4).
Finally, we wanted to examine the predicted MPRA signal of the
14 endogenous regions included in the CAGI5 data set, which were
shown to induce transcription by MPRA when tested in their
corresponding cell‐types (Kircher et al., 2018). To this end, we
trained a regression model on LCL‐eQTL regions with the full set of
features and used it to predict the MPRA activity of CAGI5 regions.
As the sequence lengths in the LCL‐eQTL were 150 base pairs, we
refeaturized the center 150 base pairs of the CAGI5 regions. We find
that when comparing the predicted MPRA activity of CAGI5 regions
with the distribution of LCL‐eQTL regions activity, most CAGI5
regions were in the >90th percentile (Figure S4). This is consistent
with our expectation that the CAGI5 regions should be recognized as
having a significant transcriptional activity.
3.4 | Contributions of individual TFs to the
accuracy of predicting MPRA outcome
We wanted to explore which factors in different cells drive the
activity of regulatory regions, and hypothesized that the protein
milieu in the cell might act as one. To this end, we examined the
contribution of individual TFs to MPRA activity. We recorded the
correlation between each TF binding signal (DeepBind prediction) and
the activity of each MPRA region (Alipanahi et al., 2015). Similarly to
our analysis in Figure 1, we then ranked the TFs based on their
predictive ability across data sets, thus revealing several TFs whose
binding is generally informative of regulatory activity of MPRA
constructs in all cellular contexts in this study (Figures 5, S8, and S9
and Table S5). For instance, two TF families with a data set‐wide high
predictive capacity, that is also supported by experimentally‐
evaluated binding from ChIP‐seq ( Figure S9 and Table S5) sites
are JUN and FOS. Proteins of the FOS family dimerize with proteins of
the JUN family, thereby forming the TF complex AP‐1, which has been
implicated in a wide range of cellular processes, including cell growth,
differentiation, and apoptosis across different cell‐types (Ameyar,
Wisniewska, & Weitzman, 2003). More generally, we find that TFs
whose binding is commonly predictive of MPRA activity across data
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sets are also highly expressed across all the three cell‐types, as
indicated by RNA‐seq data (Figure 5). Indeed, the gene expression of
TFs is overall consistent with their predictive capacity, whereby more
predictive factors have overall higher expression as measured by
RNA‐seq (Encode‐Project‐Consortium, 2012; Figure 5—right four
columns) across all cell‐types (the Wilcoxon rank sum test of top vs.
bottom 50 factors: p‐value of 3.9e−6, 1.36e−5, 8.7e−4, and 8.0e−4
for K562, LCL, HepG2, and H1hESC, respectively).
3.5 | Exploring common and distinct TF binding
between data sets
We next proceeded to explore TFs whose binding is predictive of MPRA
activity only in specific cell‐types. To this end, we defined, for each data
set, a set of predictive TFs, as the set of bound TFs (predicted by DeepBind)
that is significantly correlated with MPRA output (Spearman’s FDR
corrected p<0.05). We then compare across pairs of data sets to
determine if there is significant overlap in predictive TFs. To this end, for
each pair of data sets, we calculated the fold enrichment of the overlap
between the predictive TF set, and evaluated the significance of this
overlap using a hypergeometric p‐value (Figure 6a). Overall, we see that
there is significant overlap across every pair of data sets. Interestingly,
the similarity between data sets seem to be dominated by the similarity
between the MPRA sequences and less so by the similarity in cellular
context. Specifically, the HepG2‐chr and HepG2‐epi pair and LCL‐eQTL and
HepG2‐eQTL pair had the strongest overlap, with higher similarity
between experimental versions tested in the same cell‐type
(HepG2‐chr/HepG2‐epi) than same elements tested in different
cell‐types (LCL‐eQTL/HepG2‐eQTL), suggesting that the same genomic
regions tested in different conditions have correlated signals in MPRA.
However, this result may depend on the specific sequences studied, and
further data needs to be collected to substantiate it.
We further examine the predictive TFs that differ between pairs of
data sets (Figure 6b and Table S6), and provide a list of top predictive
TFs in at least one data set. In some cases, we find proteins whose
function is related to the cell‐type under investigation. For instance,
when comparing the two data sets with the lowest similarity score for
predictive TFs, K562 to HepG2‐eQTL, we find that RARG (a retinoic
acid receptor which belongs to the nuclear hormone receptor family
and is associated with liver risk phenotype [Roberts et al., 2010]) is
predictive in HepG2‐eQTL but not K562. When comparing K562 to
LCL‐eQTL, we observed that the genes in the ETS family (ELF1, ELF5,
ELF3, ETV6, ELK3) are predictive only in K562. These genes are
known to be expressed in hematopoietic tissues and cell lines, and
play a role in hematopoietic cell development (Clausen et al., 1997).
When comparing hESC to the other data sets, we observe a known
pluripotent factor‐ POU5F1 (Boyer et al., 2005) to be predictive only
in hESC for most of the comparisons (Table S6).
F IGURE 4 (a) LCL‐eQTL versus HepG2‐eQTL MPRA activity by log2 ɑ values. The points are colored according to activity in each of the data
sets (active/inactive is defined as above/below 1.5 cutoff, respectively). (b) We define hardness as the rank‐normalized absolute difference
between the ground truth binary activity label (0 or 1) and predicted probability. The cumulative distribution function of the hardness for each
of the four activity groups when training the ensemble, full feature cross‐data set model on HepG2‐eQTL (Left subfigure) and LCL‐eQTL (Right
subfigure), and testing on LCL‐eQTL and HepG2‐eQTL, respectively
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Overall, these results support the notion that both sequence‐
intrinsic (i.e. derived solely from the sequence tested in MPRA)
and cell‐type‐specific (i.e., derived from the cell‐type where
MPRA was tested) properties are determining MPRA activity. We
also find that the cell‐type‐specific component may be captured
by the activity of TFs whose function is associated with the
cell‐type under investigation.
3.6 | Studying the effects of small genetic variants
on MPRA output in CAGI5
MPRA can be used to study the transcriptional effects of small
variants that commonly occur in regulatory regions, namely SNVs
and small indels (Tewhey et al., 2016). We wanted to examine if we
can predict these effects using our framework. To test this, we used
the data from the CAGI5 challenge, which consisted of saturation
mutagenesis analysis of 14 regions, overall testing the effects of
17,500 SNVs. The training data consisted of 25% of the saturation
mutagenesis results in each of the 14 regions.
The participants in the CAGI5 challenge were asked to use the
training data to predict the impact of SNVs on the MPRA signal in the
held‐ out parts of the experiment. The challenge was divided in two.
In the discrete challenge part, the goal was to predict the category of
impact (negative effect, no effect, positive effect). The CAGI5
evaluators later (post submission) requested that the top performing
groups each provide a prediction of the continuous impact of each
SNV (namely, fold change of the MPRA signal); we refer to this as the
continuous challenge (Shigaki et al., 2019).
For both the discrete and the continuous challenge, we featurized
the wild‐type and variant sequences with all features that depend on
the raw sequence, including DeepSEA, DeepBind, DNA kmer‐frequen-
cies, and so forth (Section 2)—we call this collection of features the
Sequence features; we excluded the features that depend on the
genome coordinate, such as Experimental features, because those are
the same for all variants of the same element. The inputs to our
prediction problem are therefore pairs of sequences—a wild‐type
feature and a mutated feature. To train a predictive model, we
examined two ways to featurize each pair—either concatenate the
feature vectors of the wild‐type and alternative allele, or subtract the
values of the alternative allele from those of the wild‐type allele. We
found that concatenation versus subtraction made very little
difference in accuracy (data not shown) and thus focus our discussion
on the latter.
For the discrete challenge, we trained a single multiclass (−1, 0, +1;
denoting negative effect, no effect, and positive effect respectively)
classification model to predict the discretized impacts of genomic
variation. We trained a separate model for the effects of variants in
promoter sequences and in gene‐ distal sequences (Section 2). The
assessors of this challenge (Shigaki et al., 2019) evaluated accuracy
using Pearson correlation of the predicted labels (−1, 0, 1) with the
continuous MPRA expression impact scores. They also calculated the
AUROC treating this as a discretized classification task (e.g., 1 vs. [0
and −1]).
Our analysis yielded the highest average accuracy across all the
elements. Specifically, (0.318 Pearson and 0.249 Spearman;
correlations are between the predicted scores and the −1, 0, 1
F IGURE 5 Contribution of individual DeepBind transcription factor
(TF) binding for predicting regulatory activity of massively parallel
reporter assay constructs. The within‐data set ranking is calculated by
taking the per feature median rank across all classification and
regression tests. The comprehensive ranking is the per feature median
overall within‐data set rankings. TFs are sorted from best (smallest) to
worst comprehensive rank. (Left) Heatmap of the within‐data set
rankings. (Right) The per TF ranking of its messenger RNA levels
measured by RNA‐seq in each of the four cell lines. Names of the
common top/bottom 10 factors are indicated on the left
1308 | KREIMER ET AL.
labels), as well as competitive average AUROCs (0.762 for positive
vs. negative, 0.706 for positive vs. rest, 0.776 for negative vs. rest;
Table S7).
For the continuous challenge, we used the aggregated features and
trained one regression model to predict the continuous impacts of all
promoter variants and one regression model to predict the impacts
of all enhancer variants (Section 2). Across all the submissions, our
continuous impact submission tied for the best average Pearson’s
correlation across all the elements (0.451 for ours vs. 0.452 for
submission G3/cont1), and achieve best Pearson’s correlation scores
in 10 of the 14 elements (Table 1).
3.7 | Post submission analysis on CAGI5 training
data
We examined the correlation between the continuous variant impact and
the difference between variant and wild‐type Sequence features (Figure 7
and Table S8). We observe that some of the strongest features are the
ones highly correlated with MPRA activity as found in previous data sets
(Figure 1). We conclude that predictive feature differences for variant
impact are consistent with predictive features for MPRA activity.
Following the assessors recommendations (Shigaki et al., 2019),
we focused the rest of our analysis on the continuous challenge, as the
discrete challenge did not provide enough data for more in‐depth
analysis. The reason for this is that several (3 out of the 14 elements)
of the mutagenesis experiments contained as few as three variants
exhibiting what was deemed by the organizers as significantly
positive or negative impact.
We retrospectively discovered that training one regression model per
reference genomic region (14 altogether) to predict variant impact
outperforms training one regression model per type (promoter or
enhancer), so we proceeded with the former strategy. We observed that
the full set of Sequence features resulted in the best performance in all of
the enhancer and promoter elements, compared with specific feature
sets (Figure 8 and Table S9). We do not observe any significant
differences between cell‐types in terms of model performance (e.g.,
changes in activity of perturbing the DNA element telomerase reverse
transcriptase [TERT] in HEK293T cells can be predicted with high
performance [0.61 Pearson] whereas MYC tested in the same cell line
has lower performance ([0.2 Pearson]).
To examine whether predictions of SNV effect can be generalized
from one data set (here, perturbations of a single DNA element) to
F IGURE 6 Similarities and differences in transcription factors (TFs) whose binding is predictive of Massively parallel reporter assay (MPRA)
activity between data sets. For each data set, we define a set of predictive TFs, as the set of bound TFs (predicted by DeepBind) that is
significantly correlated with MPRA output (Spearman’s q < 0.05). (a) Similarity of predictive TFs between data sets. For each pair of data sets, a
hypergeometric test is performed on the sets of predictive TFs of both data sets, resulting in a q‐value indicating the likelihood of the overlap
occurring by chance (color scale). We also calculate the enrichment ratios of predictive TFs for each pair of data sets (cell text). (b) Differences in
predictive TFs between data sets. For each data set, we only plot high confidence predictive TFs (i.e., significant TFs) that have Spearman’s
q‐values of less than 0.01, and nonpredictive TFs (i.e., nonsignificant TFs) have q‐values of greater than 0.1
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the next, we applied the same procedure as before—namely training
a regression model on one data set and testing it on the remaining
ones (keeping promoters and distal elements separate). We found
that the accuracy of the predictions from cross‐data set models were
mostly weaker than the predictions from the supervised models
(Figure 9 and Table S10). We note that cross‐data set prediction
between TERT‐GBM and TERT‐HEK293T, which was trained on the
same region but tested in different cell‐types, exhibited moderate
strength compared with the supervised predictions. We observe poor
performance for cross‐element predictions in the same cell‐type, for
example, training on LDLR and testing on F9 (both promoters tested
in HepG2 cells) or training on GP1BB and testing on HBG1 (both
promoters tested in HEL 92.1.7 cells). These results suggest that for
saturation mutagenesis data, supervised prediction models using
both the same element and same cell‐type work generally better than
cross‐data sets models, highlighting the specificity of local variation
presented in this data. However, more data sets are required to
substantiate this claim. Generally, the absolute performance for
predicting variant effects is substantially lower than that achieved in
the task of predicting the transcription of individual sequences, which
can be expected as this task relates to a much more nuanced signal.
4 | DISCUSSION
MPRA holds a great promise to be a key functional tool that will
increase our understanding of gene regulatory elements and the
consequences of nucleotide changes on their activity. Although
previous studies already used MPRA to construct predictive models
of transcriptional regulation, its generalizability across cellular
contexts and its applicability for studying the endogenous genome
have not yet been systematically evaluated. Here, we study MPRA
data from a number of cellular systems to determine which features
are reflective of the cellular context (e.g., protein milieu in the cell),
and which are intrinsic to DNA sequence. We aimed to incorporate
the most recently produced MPRA data sets of endogenous
sequences in this study, but had to exclude several data sets after
quality control analysis (e.g., The data in Maricque, Dougherty, &
Cohen (2017)) consisted of few barcodes per candidate enhancer and
had significant inconsistency across replicates. The experimental
design in Ulirsch et al. (2016) included three genomic regions per
TABLE 1 Performance comparison for the CAGI5 Regulation Saturation continuous challenge for the nine promoters and five enhancers,
sorted by average Pearson’s correlation
Submission/regulatory
element G3/cont1 G7/cont (Ours) δSVM/cont (published method) G3/cont2 G5/cont
F9 0.6242 0.3906 0.4889 0.4279 0.5642
GP1BB 0.5559 0.5661 0.4206 0.3565 0.3484
HBB 0.4458 0.4156 0.3931 0.4394 0.3916
HBG1 0.571 0.5914 0.3423 0.459 0.4787
HNF4A 0.3393 0.3967 0.1335 0.2936 0.1906
LDLR 0.5025 0.4922 0.3399 0.2299 0.351
MSMB −0.0399 0.1391 0.1648 0.0819 0.0628
PKLR 0.6116 0.6667 0.4912 0.4927 0.0246
TERT(GBM) 0.5942 0.6653 0.4881 0.561 0.5224
TERT(HEK293T) 0.5283 0.5919 0.4137 0.4686 0.3609
IRF4 0.3707 0.527 0.5023 0.2639 0.0246
IRF6 0.387 0.444 0.2641 0.3566 0.2363
MYC 0.4278 0.1636 0.3366 0.2847 0.1356
SORT1 0.4743 0.4982 0.4471 0.3497 0.2363
ZFAND3 0.3872 0.2145 0.477 0.4029 0.2223
Average 0.451993 0.45086 0.380213 0.364553 0.276687
F IGURE 7 Pearson correlation between variant effect and the
difference between variant and wild‐type feature across the relevant
individual features for the nine promoters and five enhancers tested
in CAGI5. *Cells whose correlation’s p < 0.05
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enhancer, in overlapping windows. Activity measurements were
highly variable between windows of the same enhancer, while many
of the features we use were shared among the overlapping windows.
We explore the extent by which knowledge of regulatory activity in
one cellular context can be used to make predictions in a held out
cellular context. Finally, we examine the ability of our framework to
detect the effects of small variants on MPRA activity. Our results
represent, to the best of our knowledge, the first such comprehensive
analysis.
Our work highlights genome accessibility and TF binding as the
strongest predictors of regulatory activity, with no observed advantage to
cell‐type‐specific features. When applying prediction models, we observe
that performance is improved when using an ensemble of all features,
with no significant prediction improvement when using cell‐type‐specific
features. These results imply that part of the signal observed in MPRA
studies is not cell‐type specific. Interestingly, models trained with
chromosomal MPRA data yield better predictions across data sets than
those trained on episomal MPRA data, stressing the importance of this
experimental approach that conveys a more reliable representation of
the endogenous settings.
When training on one cell‐type and predicting on another cell‐
type, we observe overall lower but robust results, with regions
enriched in cell‐type‐specific signal being harder to predict. Notably,
we detect a communal component across data sets with a group of
TFs being top predictors, as well as some cell‐specific factors that
seem to be involved in phenotypes associated with the corresponding
cell‐type. In the MPRA setting the cis environment (e.g., chromatin) is
altered, thus generally not cell‐type specific, and the trans environ-
ment (e.g., TF binding) remains similar, hence we can still observe
predictive factors that are cell‐type specific.
As seen through its performance in the CAGI5 Regulation Saturation
challenge, our approach is competitive in the high‐resolution task of
predicting the functional effects of SNVs in a supervised setting.
Our work provides a comprehensive resource of annotation for
thousands of endogenous sequences across the genome. Further-
more, we demonstrate the performance of different machine learning
models for MPRA activity prediction on features generated by
publicly available tools. Our approach can highlight functionally
important regulatory regions across the genome in a cell‐type
agnostic fashion and can be leveraged for an efficient design of
future MPRA experiments by prioritizing regions of interest.
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